|
|
|
regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy1 Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA; 2 Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, CH-8057 Zurich, Switzerland; 3 Howard Hughes Medical Institute and Departments of Molecular Physiology and Biophysics, Neurology, and Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa 52242, USA
The coactivator PGC-1
mediates key responses of skeletal muscle to motor nerve activity. We show here that neuregulin-stimulated phosphorylation of PGC-1
and GA-binding protein (GABP) allows recruitment of PGC-1
to the GABP complex and enhances transcription of a broad neuromuscular junction gene program. Since a subset of genes controlled by PGC-1
and GABP is dysregulated in Duchenne muscular dystrophy (DMD), we examined the effects of transgenic PGC-1
in muscle of mdx mice. These animals show improvement in parameters characteristic of DMD, including muscle histology, running performance, and plasma creatine kinase levels. Thus, control of PGC-1
levels in skeletal muscle could represent a novel avenue to prevent or treat DMD.
[Keywords: PGC-1; neuromuscular junction; GA-binding protein; Duchenne muscular dystrophy; transcriptional regulation]
Received December 21, 2006; revised version accepted February 8, 2007.
E-MAIL bruce_spiegelman{at}dfci.harvard.edu; FAX (617) 632-4655.
Supplemental material is available at http://www.genesdev.org.
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1525107
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Vercauteren, N. Gleyzer, and R. C. Scarpulla PGC-1-related Coactivator Complexes with HCF-1 and NRF-2{beta} in Mediating NRF-2(GABP)-dependent Respiratory Gene Expression J. Biol. Chem., May 2, 2008; 283(18): 12102 - 12111. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Scarpulla Transcriptional Paradigms in Mammalian Mitochondrial Biogenesis and Function Physiol Rev, April 1, 2008; 88(2): 611 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Arany, B. K. Wagner, Y. Ma, J. Chinsomboon, D. Laznik, and B. M. Spiegelman Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1{alpha} and oxidative phosphorylation PNAS, March 25, 2008; 105(12): 4721 - 4726. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Stupka, J. D. Schertzer, R. Bassel-Duby, E. N. Olson, and G. S. Lynch Stimulation of calcineurin A{alpha} activity attenuates muscle pathophysiology in mdx dystrophic mice Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R983 - R992. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Wende, P. J. Schaeffer, G. J. Parker, C. Zechner, D.-H. Han, M. M. Chen, C. R. Hancock, J. J. Lehman, J. M. Huss, D. A. McClain, et al. A Role for the Transcriptional Coactivator PGC-1{alpha} in Muscle Refueling J. Biol. Chem., December 14, 2007; 282(50): 36642 - 36651. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Handschin, S. Chin, P. Li, F. Liu, E. Maratos-Flier, N. K. LeBrasseur, Z. Yan, and B. M. Spiegelman Skeletal Muscle Fiber-type Switching, Exercise Intolerance, and Myopathy in PGC-1{alpha} Muscle-specific Knock-out Animals J. Biol. Chem., October 12, 2007; 282(41): 30014 - 30021. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schiaffino, M. Sandri, and M. Murgia Activity-Dependent Signaling Pathways Controlling Muscle Diversity and Plasticity Physiology, August 1, 2007; 22(4): 269 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jager, C. Handschin, J. St.-Pierre, and B. M. Spiegelman AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1{alpha} PNAS, July 17, 2007; 104(29): 12017 - 12022. [Abstract] [Full Text] [PDF] |
||||